Mayo Clinic researchers have developed the first liquid biopsies from blood tests and DNA sequencing that can detect ovarian cancer long before a tumor reappears.
The advance, reported by the Mayo Clinic Center for Individualized Medicine, provides a promising new way to monitor and treat recurrences of ovarian cancer — a hard-to-detect disease that claims many lives.
Lead researcher Dr. George Vasmatzis, Ph.D., of the Department of Laboratory Medicine and Pathology at Mayo Clinic, said the development could lead to earlier intervention and more effective, individualized treatment for the often-fatal condition.
Read more
Comments are closed.